Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy. Harris E. JAMA 2024;331:280.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harris E. Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy. JAMA 2024;331:280.
PMID: 38170544